Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
The Journal of Clinical Endocrinology & MetabolismPublished 20 September 2006Open access
Shehzad Basaria, Adrian S. Dobs
Citations37
SJR quartileQ1
SJR score2.18
SNIP1.77
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
A short-term trial of transdermal testosterone therapy (once approved) in surgically menopausal (estrogenized) women with distressful sexual dysfunction is recommended and a short trial of oral methyltestosterone in deserving estrogenized women may be justified.
Abstract
We recommend a short-term trial (not to exceed 24 wk) of transdermal testosterone therapy (once approved) in surgically menopausal (estrogenized) women with distressful sexual dysfunction. Until the patch gets approval, a short trial of oral methyltestosterone in deserving estrogenized women may be justified.
Keywords
Medicine
JAMARisks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
15,680 Citations2002Jacques E. Rossouw
Overall health risks exceeded benefits from use of combined estrogen plus progestin for an average 5.2-year follow-up among healthy postmenopausal US women, and the results indicate that this regimen should not be initiated or continued for primary prevention of CHD.
JAMARandomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
6,229 Citations1998Stephen B. Hulley
Treatment with oral conjugated equine estrogen plus medroxyprogesterone acetate did not reduce the overall rate of CHD events in postmenopausal women with established coronary disease and the treatment did increase the rate of thromboembolic events and gallbladder disease.
JAMASexual Dysfunction in the United States
5,063 Citations1999Edward O. Laumann, Anthony Paik +1 more
The results indicate that sexual dysfunction is an important public health concern, and emotional problems likely contribute to the experience of these problems.
Endocrine ReviewsThe Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
1,077 Citations2005Jean‐Marc Kaufman, Alex Vermeulen
Until the long-term risk-benefit ratio for androgen administration to elderly is established in adequately powered trials of longer duration, androgen administrations to elderly men should be reserved for the minority of elderly men who have both clear clinical symptoms of hypogonadism and frankly low serum testosterone levels.
The Journal of Clinical Endocrinology & MetabolismAndrogen Levels in Adult Females: Changes with Age, Menopause, and Oophorectomy
991 Citations2005Sonia L. Davison, Robin J. Bell +3 more
It is reported that serum androgen levels decline steeply in the early reproductive years and do not vary because of natural menopause and that the postmenopausal ovary appears to be an ongoing site of testosterone production.
New England Journal of MedicineTransdermal Testosterone Treatment in Women with Impaired Sexual Function after Oophorectomy
952 Citations2000Jan Shifren, Glenn D. Braunstein +12 more
In women who have undergone oophorectomy and hysterectomy, transdermal testosterone improves sexual function and psychological well-being in women who had impaired sexual function after surgically induced menopause.
MaturitasTestosterone enhances estradiol's effects on postmenopausal bone density and sexuality
532 Citations1995Susan R. Davis, Philip McCloud +2 more
It is concluded that in postmenopausal women, treatment with combined estradiol and testosterone implants was more effective in increasing bone mineral density in the hip and lumbar spine thanEstradiol implants alone.
The Journal of Clinical Endocrinology & MetabolismEndocrine Function of the Postmenopausal Ovary: Concentration of Androgens and Estrogens in Ovarian and Peripheral Vein Blood
517 Citations1974Howard L. Judd, George E. Judd +2 more
The postmenopausal ovary continues to secrete a large amount of testosterone and a moderate amount of androstenedione and the small magnitude of the peripheral and ovarian vein estrogen differences could account for only minimal ovarian estrogen secretion.
JAMACirculating Androgen Levels and Self-reported Sexual Function in Women
506 Citations2005Susan R. Davis
The Journal of Clinical Endocrinology & MetabolismTestosterone Patch Increases Sexual Activity and Desire in Surgically Menopausal Women with Hypoactive Sexual Desire Disorder
475 Citations2005James A. Simon, Glenn D. Braunstein +11 more
In the Intimate SM 1 study, the testosterone patch improved sexual function and decreased distress in surgically menopausal women with HSDD and was well tolerated in this trial.
Archives of Internal MedicineSafety and Efficacy of a Testosterone Patch for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
458 Citations2005Glenn D. Braunstein, Dale A. Sundwall +10 more
The 300-μg/d testosterone patch increased sexual desire and frequency of satisfying sexual activity and was well tolerated in women who developed hypoactive sexual desire disorder after surgical menopause.
Fertility and SterilityFemale androgen insufficiency: the princeton consensus statement on definition, classification, and assessment
441 Citations2002Gloria Bachmann, John Bancroft +17 more
The Journal of Clinical Endocrinology & MetabolismOvarian and Adrenal Contribution to Peripheral Androgens During the Menstrual Cycle
434 Citations1974Guy E. Abraham
Obstetrics and GynecologyTestosterone Patch for Low Sexual Desire in Surgically Menopausal Women: A Randomized Trial
427 Citations2005John E. Buster, Sheryl A. Kingsberg +7 more
In surgically menopausal women with hypoactive sexual desire disorder, a 300 μg/d testosterone patch significantly increased satisfying sexual activity and sexual desire, while decreasing personal distress, and was well tolerated through up to 24 weeks of use.
The Journal of Clinical Endocrinology & MetabolismA Prospective Longitudinal Study of Serum Testosterone, Dehydroepiandrosterone Sulfate, and Sex Hormone-Binding Globulin Levels through the Menopause Transition<sup>1</sup>
407 Citations2000Henry Burger, Emma Dudley +3 more
It is concluded that SHBG and FAI levels change at the time of the menopause, at least partially due to the decline in E2.
Psychosomatic MedicineThe role of androgen in the maintenance of sexual functioning in oophorectomized women.
394 Citations1987B B Sherwin, Morrie M. Gelfand
It is suggested that androgen may be critical for the maintenance of optimal levels of sexual functioning in postmenopausal women.
The Journal of Clinical Endocrinology & MetabolismThe Hormonal Activity of the Postmenopausal Ovary
383 Citations1976A. Vermeulen
It is concluded that the adrenal cortex is almost the exclusive source of plasma estradiol, estrone, progesterone, and 17OH progester one and the most important source of Plasma dehydroepiandrosterone and that hCG stimulation with 5000 IU daily for 3 days, hardly influences steroid secretion by postmenopausal ovaries.
The Journal of Clinical Endocrinology & MetabolismTwenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women.
377 Citations1995B Zumoff, Gladys Strain +2 more
The 24-h mean plasma concentration of total testosterone (T) was measured in 33 healthy, regularly cycling, nonobese women between 21 and 51 yr of age and found that the concentration showed a steep decline with age; the regression equation was T (nanomoles per L) = 37.8 x age-1.12.
Maturitas“Reprint of” A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density
350 Citations2008Gunnar Rannevik, Sten Jeppsson +4 more
From a longitudinal prospective study, 160 women with spontaneous menopause and without steroid medication were followed during the transition from pre- to postmenopause, finding that body mass index (BMI) showed an inverse correlation with SHBG and postmenopausal androstenedione correlated positively with E1, E2 and T, and BMI correlated positivelyWith E1 and E2.
Fertility and SterilityHormones, mood, sexuality, and the menopausal transition
348 Citations2002Lorraine Dennerstein, John F. Randolph +3 more
Female sexual functioning declines with the natural menopausal transition, and this decline relates more to decreasing estradiol levels than to androgen levels.
The Journal of Clinical Endocrinology & MetabolismHysterectomy, Oophorectomy, and Endogenous Sex Hormone Levels in Older Women: The Rancho Bernardo Study<sup>1</sup>
346 Citations2000Gail A. Laughlin, Elizabeth Barrett‐Connor +2 more
It is demonstrated that the postmenopausal ovary remains a critical source of androgen throughout the lifespan of older women and the clinical consequences of lower testosterone levels years after oophorectomy are unknown.
Fertility and SterilityAre changes in sexual functioning during midlife due to aging or menopause?
342 Citations2001Lorraine Dennerstein, Emma Dudley +1 more
Sexual responsivity is adversely affected by both aging and the menopausal transition, and other domains of female sexual functioning were significantly adversely affected when the women became postmenopausal.
The Journal of Clinical Endocrinology & MetabolismPhysiological Changes in Dehydroepiandrosterone Are Not Reflected by Serum Levels of Active Androgens and Estrogens But of Their Metabolites: Intracrinology
336 Citations1997Fernand Labrie, Alain Bélanger +2 more
The Journal of Clinical Endocrinology & MetabolismThe endocrinology of the menopausal transition: a cross-sectional study of a population-based sample.
325 Citations1995Henry Burger, E. C. DUDLEY +6 more
An increase in serum FSH and decreases in E2 and INH are the major endocrine changes associated cross-sectionally with the menopausal transition.
MaturitasA longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density
294 Citations1995Gunnar Rannevik, Sten Jeppsson +4 more
From a longitudinal prospective study, 160 women with spontaneous menopause and without steroid medication were followed during the transition from pre- to postmenopause, finding that body mass index (BMI) showed an inverse correlation with SHBG and postmenopausal androstenedione correlated positively with E1, E2 and T, and BMI correlated positivelyWith E1 and E2.
American Journal of Obstetrics and GynecologyDifferential symptom response to parenteral estrogen and/or androgen administration in the surgical menopause
261 Citations1985Barbara B. Sherwin, Morrie M. Gelfand
The data suggest that reduced levels of circulating testosterone subsequent to bilateral oophorectomy may play an important role in the development of physical and psychological symptoms that are frequent sequelae of this surgical procedure.
American Journal of Obstetrics and GynecologyEffect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer
259 Citations1974Howard L. Judd, William E. Lucas +1 more
Obstetrics and GynecologyRisks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Womenʼs Health Initiative randomized controlled trial
251 Citations2003
Principal results are reported for the trial of combined estrogen and progestin in women with a uterus that was stopped early based on health risks that exceeded health benefits over an average follow-up of 5.2 years.
The Journal of Clinical Endocrinology & MetabolismCorrelates of Circulating Androgens in Mid-Life Women: The Study of Women’s Health Across the Nation
248 Citations2005Nanette Santoro, Javier I. Torréns +10 more
Circulating SHBG and androgens are most strongly associated with physical characteristics and the metabolic syndrome in women in this community-based cohort.
Fertility and SterilityComparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire
239 Citations2003Rogerio A. Løbo, Raymond C. Rosen +3 more
Fertility and SterilityThe climacteric ovary as a functional gonadotropin-driven androgen-producing gland
217 Citations1994Eli Y. Adashi
The climacteric ovary is not a defunct endocrine organ and appears to be a gonadotropin-dependent androgen-producing gland, although the estrogen-producing potential of the climacterics ovary remains a matter of controversy.
Endocrine ReviewsTestosterone Effects on the Breast: Implications for Testosterone Therapy for Women
216 Citations2004Woraluk Somboonporn, Susan R. Davis
Exogenous testosterone may serve as a natural endogenous protector of the breast and limit mitogenic and cancer-promoting effects of estrogen on mammary epithelium, and inclusion of testosterone in postmenopausal estrogen-progestin regimens has the potential to ameliorate the stimulating effects of combined estrogen- Progestin on the breast.
The Journal of Clinical Endocrinology & MetabolismThe Postmenopausal Ovary Is Not a Major Androgen-Producing Gland
210 Citations2001Béatrice Couzinet, Geri Méduri +6 more
In the absence of adrenal steroids, postmenopausal women have no circulating androgen levels and the climacteric ovary is not a critical source of androgens.
Journal of Psychosomatic Obstetrics & GynecologyElective ovarian removal and estrogen replacement therapy — effects on sexual life, psychological well-being and androgen status
191 Citations1993J. Nathorst Böös, Bo von Schoultz +1 more
In oophorectomized women sexual life was impaired as compared to those with intact ovaries and these women complained about less pleasure from coitus, impaired libido and lubrication, indicating that estrogens are of little value in treating these specific sexual dysfunctions.
The Journal of Clinical Endocrinology & MetabolismSex Differences in the Twenty-Four-Hour Mean Plasma Concentrations of Dehydroisoandrosterone (DHA) and Dehydroisoandrosterone Sulfate (DHAS) and the DHA to DHAS Ratio in Normal Adults*
188 Citations1980Barnett Zumoff, Robert Rosenfeld +3 more
The two steroids showed a clear-cut linear inverse correlation between concentration and age in both sexes, and menopause was "nonevent" in the age progression for both steroids in the women.
MaturitasThe management of persistent menopausal symptoms with oestradiol-testosterone implants: Clinical, lipid and hormonal results
187 Citations1984Henry Burger, J. Hailes +4 more
It is concluded that the hormonal implants provided substantial symptomatic relief, particularly of loss of libido, while causing rises to mid-follicular concentrations of oestradiol and maximal testosterone levels about three times normal, without significant effects on plasma lipids.
The Journal of Clinical Endocrinology & MetabolismOral Dehydroepiandrosterone for Adrenal Androgen Replacement: Pharmacokinetics and Peripheral Conversion to Androgens and Estrogens in Young Healthy Females after Dexamethasone Suppression
185 Citations1998Wiebke Arlt, Hans-Georg Justl +7 more
50 mg DHEA seems to be a suitable replacement dose in females with adrenal insufficiency, and the rapid and lasting conversion to potent androgens demonstrates a potential role of D HEA for androgen replacement in females in general.
PubMedEstrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses.
183 Citations1998Philip M. Sarrel, B Dobay +1 more
Sexual desire, satisfaction and frequency in postmenopausal women taking hormonal therapy were improved significantly by combined estrogen-androgen therapy but not by estrogen or estrogen-progestin therapy, leading to the conclusion that androgens play a pivotal role in sexual function but that estrogens are not a significant factor determining levels of sexual drive and enjoyment.
The Journal of Clinical Endocrinology & MetabolismEffects of Estrogen, Androgen, and Progestin on Sexual Psychophysiology and Behavior in Postmenopausal Women*
177 Citations1990Lin S. Myers, Jean M. Dixen +3 more
The Journal of Clinical Endocrinology & MetabolismDifferential Effects of Oral Estrogen<i>versus</i>Oral Estrogen-Androgen Replacement Therapy on Body Composition in Postmenopausal Women
168 Citations2002Adrian S. Dobs, Tam Nguyen +2 more
In conclusion, E/A replacement therapy can improve body composition, lower-body muscle strength, quality of life, and sexual functioning in postmenopausal women.
CancerAndrogen receptors in breast cancer
165 Citations1984Robert M. Bryan, Ronald J. Mercer +4 more
Patients who had received tamoxifen as treatment for advanced disease were assessed for objective response and androgen receptor data added significantly to the information provided by estrogen receptors both in terms of response to hormone treatment and survival.
Clinical ChemistryThe analog free testosterone assay: are the results in men clinically useful?
160 Citations1998Stephen J. Winters, David E. Kelley +1 more
The Coat-A-Count free testosterone concentration in men, like the total testosterone concentration, is determined in part by plasma SHBG, and androgen deficiency may be misclassified with this assay in men with low SHBG.
BJOG An International Journal of Obstetrics & GynaecologyENDOCRINE CHANGES AND SYMPTOMATOLOGY AFTER OOPHORECTOMY IN PREMENOPAUSAL WOMEN
139 Citations1977Sudip Chakravarti, William P. Collins +3 more
The symptomatic and endocrine changes following hysterectomy and bilateral oophorectomy have been studied in 100 patients, 1 to 31 years after surgery and there was no correlation between plasma hormone levels and the presence of vasomotor symptoms or depression.
ClimactericAddition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being
138 Citations2002Angelique Flöter Rådestad, J. Nathorst‐Böös +2 more
The addition of testosterone undecanoate improved specific aspects of sexual function more than treatment with estrogen alone, and improvements in well-being and self-esteem were similar for both treatments.
Gynecologic and Obstetric InvestigationPsychological Reactions and Sexual Life after Hysterectomy with and without Oophorectomy
128 Citations2010J. Nathorst‐Böös, Bo von Schoultz
The Journal of Clinical Endocrinology & MetabolismEndocrine activity of the postmenopausal ovary: the effects of pituitary down-regulation and oophorectomy.
127 Citations1995Alexander V Sluijmer, M.J. Heineman +2 more
T production by the postmenopausal ovary is in part stimulated by the high levels of circulating gonadotropins, although pituitary down-regulation does not completely abolish androgenic activity.
Acta Obstetricia Et Gynecologica ScandinavicaIs sexual life influenced by transdermal estrogen therapy?
120 Citations1993J. Nathorst‐Böös, Ingela Wiklund +3 more
A correlation between improved sexual life and quality of life was also found when the results from the McCoy scale were compared with a battery ofquality of life questionnaires.
American Journal of EpidemiologyGlucose and Insulin Components of the Metabolic Syndrome Are Associated with Hyperandrogenism in Postmenopausal Women: The Atherosclerosis Risk in Communities Study
119 Citations2004Sherita Hill Golden
In multivariate analyses, the three-component metabolic syndrome combinations that contained both hyperinsulinemia and hyperglycemia were most strongly associated with increased FAI, and the role of androgens in glucose homeostasis in postmenopausal women requires further study.
The Journal of Clinical Endocrinology & MetabolismSuppression of Postmenopausal Ovarian Steroidogenesis With the Luteinizing Hormone-Releasing Hormone Agonist Goserelin*
113 Citations1988Mitch Dowsett, B.M.J. Cantwell +3 more
The continued dependence of ovarian androgen secretion on gonadotropin stimulation after the menopause may explain the responses of some patients to LHRH agonists and some other therapeutic agents of unknown or uncertain modes of action.
PubMedSerum and urinary androgens and risk of breast cancer in postmenopausal women.
113 Citations1991Giorgio Secreto, Paolo Toniolo +7 more
It is suggested that endogenous androgenic hormones may play an important role in the epidemiology of postmenopausal breast cancer in women and risk of breast cancer was positively associated with levels of all androgens in serum and urine.
BJOG An International Journal of Obstetrics & GynaecologyHormonal treatments of sexual unresponsiveness in postmenopausal women: a comparative study
111 Citations1983Michael G. Dow, D. M. Hart +1 more
Although it is not possible to identify the reasons for change, the results indicate no advantages of supplementary testosterone administration over oestradiol alone for sexually unresponsive postmenopausal women.
The Journal of Clinical Endocrinology & MetabolismPhysiological Changes in Dehydroepiandrosterone Are Not Reflected by Serum Levels of Active Androgens and Estrogens But of Their Metabolites: Intracrinology
110 Citations1997Fernand Labrie
American Journal of Obstetrics and GynecologySexual response after hysterectomy-oophorectomy: Recent studies and reconsideration of psychogenesis
103 Citations1981Leon Zussman, Shirley Zussman +2 more
Fertility and SterilityEvidence for diminished midcycle ovarian androgen production in older reproductive aged women
94 Citations1996Taonei I. Mushayandebvu, V. Daniel Castracane +3 more
The finding of diminished concentrations of both free T and A suggests that these hormones are produced in lesser quantity at midcycle in older women, suggesting that an ovarian and not adrenal process is involved.
Journal of Biosocial ScienceDecline in Coital Rates with Spouses' Ages and Duration of Marriage
79 Citations1983William H. James
Cross-sectional and longitudinal study begun in 1974 of a large U.S. urban sample confirms that mean marital coital rates decline very rapidly over the 1st year of marriage.
UrologyPrevalence of female sexual dysfunction in gynecologic and urogynecologic patients according to the international consensus classification
75 Citations2003Ingrid Geiss, Wolfgang Umek +4 more
No statistically significant difference in FSD was found between the younger and older patients seeking help in a gynecologic or urogynecologic outpatient clinic and this systematic framework facilitates methodologic examination.
EndocrinologySynergistic Effect of Glucocorticoids on the Stimulation of Progesterone Production by Follicle-Stimulating Hormone in Cultured Rat Granulosa Cells*
72 Citations1981Eli Y. Adashi, P. Jones +1 more
It is indicated that glucocorticoids synergize with FSH and other trophic agents in the accumulation of progesterone in accordance with their glucoc Corticoid rather than mineralocortICoid potencies and that this direct effect may be accounted for, at least in part, by the stimulation of 3 beta-hydroxysteroid dehydrogenase and the inhibition of 20 alpha-hydrogenase.
The Journal of UrologySafety and Efficacy of a Testosterone Patch for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women: a Randomized, Placebo-Controlled Trial
67 Citations2006Glenn D. Braunstein, Dale A. Sundwall +10 more
The 300-microg/d testosterone patch increased sexual desire and frequency of satisfying sexual activity and was well tolerated in women who developed hypoactive sexual desire disorder after surgical menopause.
The Journal of Clinical Endocrinology & MetabolismThe Postmenopausal Ovary Is Not a Major Androgen-Producing Gland
57 Citations2001B. Couzinet
The Journal of Clinical Endocrinology & MetabolismDifferential Effects of Oral Estrogen versus Oral Estrogen-Androgen Replacement Therapy on Body Composition in Postmenopausal Women
54 Citations2002A. S. Dobs
The Journal of Clinical Endocrinology & MetabolismOral Dehydroepiandrosterone for Adrenal Androgen Replacement: Pharmacokinetics and Peripheral Conversion to Androgens and Estrogens in Young Healthy Females after Dexamethasone Suppression
52 Citations1998Wiebke Arlt
International Journal of Gynecology & ObstetricsEffect of Hysterectomy, Oophorectomy and Estrogen Therapy on Libido
50 Citations1975Wulf H. Utian
Utian, W. H. and Groote Schuur Hospital, Cape Town, South Africa: Handbook of Gynaecology, 2nd Ed.
Mayo Clinic ProceedingsSafety and Adverse Effects of Androgens: How to Counsel Patients
41 Citations2004Shehzad Basaria, Adrian S. Dobs
It is believed that long-term studies are necessary to observe the potential effect of androgen replacement on cardiovascular mortality, breast and endometrial tissues, and mood and anger before this therapy can be used routinely in women.
Journal of Biological ChemistryVariation in steroid 5 alpha-reductase activity in cloned human skin fibroblasts. Shift in phenotypic expression from high to low activity upon subcloning.
38 Citations1981James E. Griffin, Diane R. Allman +2 more
Variability among normal genital skin strains is also due to inherent differences in the range of enzyme activities, which suggests that the numbers of high and low activity cells in a given explant influence the overall enzyme activity.
Seminars in Reproductive MedicineAndrogen Metabolism and the Menopause
32 Citations1998Christopher Longcope
The pathways of metabolism are not altered at the menopause but aromatization of DHEA, A, and T to estrone and estradiol all increase with age, so androgen metabolism in general is affected more by age than by theMenopause itself.
PubMedSome aspects of prophylactic oophorectomy and ovarian carcinoma.
31 Citations1981Hans Grundsell, G. Ekman +6 more
It is estimated that about one hundred out of the approximately thousand women per year who now develop ovarian cancer in Sweden could be saved if prophylactic oophorectomy were practised in this country.
Obstetrical & Gynecological SurveyCirculating Androgen Levels and Self-Reported Sexual Function in Women
26 Citations2005Susan R. Davis, Sonia L. Davison +2 more
Endocrinology and Metabolism Clinics of North AmericaEndocrine function of the postmenopausal ovary
25 Citations2004Paolo Rinaudo, Jerome F. Strauss
The current authors believe that the postmenopausal ovary has lost a clinically significant estrogenic capability, but a definitive conclusion regarding androgen production cannot be forthcoming.
Fertility and SterilityGonadotropin Binding Sites in Human Postmenopausal Ovaries
25 Citations1976John J. Peluso, Richard W. Steger +2 more
Since these cells contain G6PD and other enzymes necessary for steroidogenesis and also have the capacity to bind both hLH and hFSH, steroidogenesis in postmenopausal ovaries appears to be controlled by circulating gonadotropins.
International Journal of Gynecology & ObstetricsBinding sites for gonadotropins in human postmenopausal ovaries
24 Citations1989Ryuichi Nakano, K Shima +4 more
The results of the present study suggest that postmenopausal ovaries contain specific binding sites for pituitary gonadotropins and play a role in ovarian steroidogenesis.
British Journal of CancerUse of luteinising hormone-releasing hormone agonist (leuprorelin) in advanced post-menopausal breast cancer: clinical and endocrine effects
23 Citations1989I.L. Crighton, Mitch Dowsett +3 more
The lowering of serum testosterone suggests that androgens in post-menopausal women may be partly produced by the ovaries, stimulated by LH and FSH, as it would decrease the substrate for the peripheral synthesis of oestrogens.
Obstetrical & Gynecological SurveyTransdermal Testosterone for Women:
22 Citations2003Norman A. Mazer, Jan L. Shifren
Although still in development, transdermal testosterone therapy appears to be a promising new approach for providing physiologically based androgen therapy to women.
Obstetrical & Gynecological SurveyPsychological Reactions and Sexual Life After Hysterectomy With and Without Oophorectomy
3 Citations1993J. Nathorst‐Böös, Bo von Schoultz
…